Amplify Weight Loss Drug & Treatment ETF (THNR)
NYSEARCA: THNR · Real-Time Price · USD
24.66
-0.11 (-0.44%)
Mar 6, 2026, 4:00 PM EST - Market closed

THNR Holdings List

Mar 5, 2026
No.SymbolName WeightShares
1LLYEli Lilly and Company12.05%519
2NVONovo Nordisk A/S9.70%10,513
3AMGNAmgen Inc.7.70%887
4TYO: 4519Chugai Pharmaceutical Co., Ltd.7.58%5,200
5REGNRegeneron Pharmaceuticals, Inc.6.79%376
6TYO: 4507Shionogi & Co., Ltd.6.24%12,100
7MRKMerck & Co., Inc.5.84%2,132
8SWX: ROGRoche Holding AG5.59%527
9LON: AZNAstraZeneca PLC5.45%1,168
10ABBVAbbVie Inc.5.16%940
11PFEPfizer Inc.5.15%8,199
12HKG: 1801Innovent Biologics, Inc.4.50%19,000
13HKG: 1093CSPC Pharmaceutical Group Limited4.18%152,000
14ARWRArrowhead Pharmaceuticals, Inc.3.86%2,569
15SRRKScholar Rock Holding Corporation1.76%1,615
16CPH: ZEALZealand Pharma A/S1.75%1,295
17VKTXViking Therapeutics, Inc.1.66%2,236
18HIMSHims & Hers Health, Inc.1.56%4,169
19AGPXXShort-Term Investment Trust - Invesco Government & Agency Portfolio1.30%55,213
20KRX: 128940Hanmi Pharm. Co., Ltd.1.03%123
21JNGHFJiangsu Hengrui Pharmaceuticals Co Ltd Ordinary Shares - Class H0.83%4,400
22n/aOTHER ASSETS AND LIABILITIES0.30%158,497,815
23n/aUS DOLLARS0.01%353
As of Mar 5, 2026